DK2253701T3 - Fremgangsmåde til ekstraktion af en virus fra en cellekultur - Google Patents

Fremgangsmåde til ekstraktion af en virus fra en cellekultur

Info

Publication number: DK2253701T3
Authority: DK; Denmark
Prior art keywords: virus; extracting; cell culture; culture; cell
Prior art date: 2001-03-16

Application number

DK10171853.4T

Other languages

English (en)

Inventor

Matthew Coffey

Bradley Thompson

Original Assignee

Oncolytics Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-16

Filing date

2002-03-11

Publication date

2014-10-20

2002-03-11 Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc

2014-10-20 Application granted granted Critical

2014-10-20 Publication of DK2253701T3 publication Critical patent/DK2253701T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12251—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Oncology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK10171853.4T 2001-03-16 2002-03-11 Fremgangsmåde til ekstraktion af en virus fra en cellekultur DK2253701T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27673401P	2001-03-16	2001-03-16
EP02708064A EP1370643A1 (en)	2001-03-16	2002-03-11	Method of extracting virus from cell culture

Publications (1)

Publication Number	Publication Date
DK2253701T3 true DK2253701T3 (da)	2014-10-20

Family

ID=29420186

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK10171853.4T DK2253701T3 (da)	2001-03-16	2002-03-11	Fremgangsmåde til ekstraktion af en virus fra en cellekultur

Country Status (13)

Country	Link
US (2)	US6808916B2 (da)
EP (2)	EP2253701B1 (da)
JP (2)	JP4087712B2 (da)
AR (1)	AR034216A1 (da)
BR (1)	BR0207527A (da)
CA (1)	CA2437962C (da)
DK (1)	DK2253701T3 (da)
ES (1)	ES2500645T3 (da)
IL (2)	IL157304A0 (da)
MX (1)	MXPA03007535A (da)
NZ (1)	NZ527525A (da)
WO (1)	WO2002074940A1 (da)
ZA (1)	ZA200306228B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0309659A (pt)	2002-04-30	2005-02-22	Oncolytics Biotech Inc	Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
EP1634947A4 (en) *	2003-06-10	2007-10-03	Shimadzu Corp	EXTRACT FROM A CULTURED MAMMALIAN CELL, PROCESS FOR THEIR PREPARATION AND METHOD FOR CELL-FREE PROTEIN SYNTHESIS USING THE EXTRACT
US7901921B2 (en) *	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
EP1917351A4 (en)	2005-08-01	2009-12-16	Univ Technologies Int	ATTENUATED REOVIRUS
CA2678721C (en)	2007-03-12	2018-02-13	Oncolytics Biotech Inc.	Reoviruses having modified sequences
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
TW200909581A (en) *	2007-05-21	2009-03-01	Oncolytics Biotech Inc	Mutant reoviruses and methods of making and using
US20100247622A1 (en) *	2007-10-22	2010-09-30	Oncolytics Biotech Inc.	Treatment regime for proliferative disorders
CN201163385Y (zh) *	2008-01-15	2008-12-10	昆山渝榕电子有限公司	笔记本电脑及其脚垫
MX339014B (es) *	2008-05-27	2016-05-09	Oncolytics Biotech Inc	Modulacion de presion intersticial y suministro y distribucion viral oncolitica.
CN102065873A (zh) *	2008-05-27	2011-05-18	昂科利蒂克斯生物科技公司	在溶瘤呼肠孤病毒治疗中消除促炎细胞因子的产生
EA201390812A1 (ru)	2010-12-02	2013-11-29	Онколитикс Байотек Инк.	Лиофилизированные вирусные составы
MX373096B (es)	2010-12-02	2020-04-27	Oncolytics Biotech Inc	Formulaciones virales líquidas.
US20120273424A1 (en)	2011-04-29	2012-11-01	Oncolytics Biotech Inc.	Methods of purifying viruses using gel permeation chromatography
HK1220224A1 (zh) *	2013-03-15	2017-04-28	Ansun Biopharma, Inc.	蛋白纯化的新颖方法
ES2796950T3 (es)	2013-11-15	2020-11-30	Oncolytics Biotech Inc	Virus oncolíticos y regímenes reforzados para tratamiento de cáncer
US10280199B2 (en)	2014-02-07	2019-05-07	Phibro Animal Health Corporation	Coronavirus proteins and antigens
WO2016130569A1 (en) *	2015-02-09	2016-08-18	Mj Biologics, Inc.	A composition comprising pedv antigens and methods for making and using the composition
EA034503B1 (ru) *	2014-07-24	2020-02-14	Янссен Вэксинс Энд Превеншн Б.В.	Способ выделения полиовируса из культур клеток
GB201417042D0 (en)	2014-09-29	2014-11-12	Fkd Therapies Oy	Method
SG11202003793WA (en)	2017-10-30	2020-05-28	Baxalta GmbH	Environmentally compatible detergents for inactivation of lipid-enveloped viruses
BR112020013426A2 (pt)	2018-02-28	2020-12-01	Regeneron Pharmaceuticals, Inc.	métodos para identificação de um vírus em uma amostra e para detecção de ácidos nucleicos virais em uma amostra de cultura de células
WO2023277173A1 (ja) *	2021-06-30	2023-01-05	旭化成メディカル株式会社	ウイルスの回収方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja)	1986-08-11	1988-02-25	Biseibutsu Kagaku Kenkyusho:Kk	豚のレオウイルス感染症ワクチン
US5614413A (en) *	1993-07-01	1997-03-25	The Uab Research Foundation	Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
HRP950097A2 (en) *	1994-03-08	1997-06-30	Merck & Co Inc	Hepatitis a virus culture process
US6146873A (en) *	1994-11-10	2000-11-14	Baxter Aktiengesellschaft	Production of orthomyxoviruses in monkey kidney cells using protein-free media
WO1998022588A2 (en) *	1996-11-20	1998-05-28	Introgen Therapeutics, Inc.	An improved method for the production and purification of adenoviral vectors
US6214333B1 (en) *	1997-07-08	2001-04-10	Texas Heart Institute	Vasoprotective recombinant adenovirus vector containing a human TFPI gene
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
TWI289158B (en)	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus

2002
- 2002-03-11 CA CA002437962A patent/CA2437962C/en not_active Expired - Lifetime
- 2002-03-11 ES ES10171853.4T patent/ES2500645T3/es not_active Expired - Lifetime
- 2002-03-11 MX MXPA03007535A patent/MXPA03007535A/es active IP Right Grant
- 2002-03-11 JP JP2002574332A patent/JP4087712B2/ja not_active Expired - Lifetime
- 2002-03-11 EP EP10171853.4A patent/EP2253701B1/en not_active Expired - Lifetime
- 2002-03-11 BR BR0207527-0A patent/BR0207527A/pt not_active IP Right Cessation
- 2002-03-11 IL IL15730402A patent/IL157304A0/xx unknown
- 2002-03-11 DK DK10171853.4T patent/DK2253701T3/da active
- 2002-03-11 WO PCT/CA2002/000331 patent/WO2002074940A1/en not_active Ceased
- 2002-03-11 NZ NZ527525A patent/NZ527525A/en unknown
- 2002-03-11 EP EP02708064A patent/EP1370643A1/en not_active Withdrawn
- 2002-03-14 AR ARP020100923A patent/AR034216A1/es unknown
- 2002-03-14 US US10/097,183 patent/US6808916B2/en not_active Expired - Lifetime
2003
- 2003-08-07 IL IL157304A patent/IL157304A/en active IP Right Grant
- 2003-08-12 ZA ZA200306228A patent/ZA200306228B/en unknown
2004
- 2004-08-10 US US10/916,378 patent/US7186542B2/en not_active Expired - Lifetime
2007
- 2007-08-15 JP JP2007211995A patent/JP2007295937A/ja active Pending

Also Published As

Publication number	Publication date
EP2253701B1 (en)	2014-08-13
EP2253701A1 (en)	2010-11-24
BR0207527A (pt)	2004-02-25
JP2007295937A (ja)	2007-11-15
US7186542B2 (en)	2007-03-06
ES2500645T3 (es)	2014-09-30
CA2437962A1 (en)	2002-09-26
HK1150859A1 (en)	2012-01-13
WO2002074940A1 (en)	2002-09-26
CA2437962C (en)	2005-11-15
EP1370643A1 (en)	2003-12-17
ZA200306228B (en)	2004-08-12
IL157304A0 (en)	2004-02-19
US20050095692A1 (en)	2005-05-05
JP4087712B2 (ja)	2008-05-21
JP2004520841A (ja)	2004-07-15
IL157304A (en)	2010-04-29
US20020168764A1 (en)	2002-11-14
US6808916B2 (en)	2004-10-26
AR034216A1 (es)	2004-02-04
MXPA03007535A (es)	2003-12-11
NZ527525A (en)	2005-03-24

Publication	Publication Date	Title
DK2253701T3 (da)	2014-10-20	Fremgangsmåde til ekstraktion af en virus fra en cellekultur
DK1349918T3 (da)	2014-11-10	Fremgangsmåde til indsamling af stamceller fra moderkagen
DK1360287T4 (da)	2019-06-11	Fremgangsmåder til modifikation af eukaryotiske celler
IS7992A (is)	2005-08-18	Dýralaus frumuræktunar aðferð
DK2574662T3 (da)	2021-09-20	Fremgangsmåde til elektroporation af biologiske prøver
DK1918364T3 (da)	2011-08-29	Fremgangsmåde til rekloning af produktionsceller
DK1585630T3 (da)	2008-08-18	Fremgangsmåde til ekstraktion af kontaktlinser
IL164551A (en)	2010-05-17	Method for producing a virus from a cell culture
DK1743939T3 (da)	2011-12-12	Fremgangsmåde til isolering af RNA fra formalinfikserede, paraffinindlejrede vævsprøver
DK1692295T3 (da)	2013-06-17	Immobilisering af enzymer ved template-styret silikatpræcipitation
IS6316A (is)	2002-09-30	Aðferð til erfðafræðilegra greininga
DK1978747T3 (da)	2014-06-10	Fremgangsmåde til fjernelse af kodningsforvrængning
DK1244702T3 (da)	2006-08-28	Fremgangsmåde til udvinding af osteopontin fra mælk
DK2135957T3 (da)	2019-05-13	Fremgangsmåde til fremstilling af glucaner
DK1308198T3 (da)	2006-09-25	Fremgangsmåde og system til fjernelse af kviksölv
IS6521A (is)	2002-08-22	Aðferð til að hreinsa gerjunarseyði
DK1512324T3 (da)	2006-12-27	Fremgangsmåde til dearomatisering af materialer stammende fra soja
DK1456281T3 (da)	2006-03-27	Fremgangsmåde til genvinding af en polymer fra en oplösning
DK1212084T3 (da)	2006-07-10	Fremgangsmåde til adskillelse af rotavirus-varianter samt levende, svækket rotavirus-vaccine
DK0964876T3 (da)	2001-10-08	Fremgangsmåde til ekstraktion af halvraffineret carragenan fra alger
DK1345944T3 (da)	2005-05-30	Fremgangsmåde til isolering og oprensning af epothiloner
FI20002698L (fi)	2002-06-09	Menetelmä elohopean poistamiseksi kaasusta
DK1575941T3 (da)	2012-07-09	Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1294659T3 (da)	2008-03-17	Fremgangsmåde til isolering af katamin
DK1362040T3 (da)	2005-01-24	Fremgangsmåde til fremstilling af mesylater af piperidinderivater